Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

A total of 36 consecutive patients with AML in CR underwent reduced-intensity allogeneic hematopoietic SCT (RISCT) with fludarabine and melphalan conditioning. All patients were ineligible for myeloablative transplantation because of age or comorbidity. In total, 30 patients were in first CR and six...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bone Marrow Transplant
Autori principali: Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320641/
https://ncbi.nlm.nih.gov/pubmed/21423123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.61
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi